Abstract
Purpose: The purpose of this study was to correlate the degree of ocular hypertension with the number of Ozurdex injections. Methods: Intraocular pressure (IOP) fluctuations for a total of 183 injections were studied over a period of at least 12 months. The main indications for treatment were uveitis, diabetic macular edema, and retinal vein occlusion. Results: Results of the study demonstrate that repeated Ozurdex injections do not increase the frequency of IOP spikes beyond 30 mmHg. For lower IOPs, however, a positive correlation exists. Furthermore, patients with primary open angle glaucoma and uveitis had the highest IOP response to repeated injections. On average, patients with an IOP of ≥28.6 mmHg received pressure lowering medications, after which their IOP reached a stable level (16.7 mmHg) without the need for additional interventions. Conclusion: The data support the conclusion that multiple Ozurdex injections does not increase the frequency of IOP spikes beyond 30 mmHg, but patients still must be closely monitored if they have a history of primary open angle glaucoma.
Original language | English (US) |
---|---|
Pages (from-to) | 639-642 |
Number of pages | 4 |
Journal | Clinical Ophthalmology |
Volume | 12 |
DOIs | |
State | Published - Apr 3 2018 |
Keywords
- Dexamethasone
- Glaucoma
- Intraocular pressure
- Ocular hypertension
- Ozurdex
ASJC Scopus subject areas
- Ophthalmology